"It was fun to speak at the LDV Vision Summit and to dream about the future with Evan. I am always inspired by founders harnessing AI to create the next breakthrough in visual technologies." - Roelof Botha, Managing Partner and Steward of Sequoia Capital 

“The explosion of AI coupled with visual technology and the ability to train models on multimodal data is a huge unlock for the life sciences. It was a privilege to moderate a panel of experts pushing the boundaries of overcoming complex genetic diseases, improving healthspan, and creating actionable insights into environmental impacts on health.” - Dr. Laura Smoliar, Executive Director, Taiwan Science & Technology Hub @ Stanford University and our LDV Capital Expert

"LDV has been a big part of our journey at Synthesia from zero to Unicorn. It was great to join the LDV Vision Summit with such a wide range of innovative technologies all based around the common theme - the impact of visual technologies and AI. I hope Synthesia adds a small part to the big picture, it is an honor to be part of the community." - Dr. Jon Starck, CTO at Synthesia, one of LDV Capital’s portfolio companies

“Thanks for the invitation to join this year’s LDV Vision Summit! I had a great time discussing how the advancement of AI and integration with the lab are transforming science broadly – from biology to generating essential medicines to inorganic materials solving critical challenges in climate change. I’m most excited by the potential to marry AI, visual technologies, and robotics to transform the integration of AI with the physical world of science.” - Dr. Molly Gibson, co-founder and chief strategy and innovation officer at Generate Biomedicines, Origination Partner at Flagship Pioneering

“The summit enabled us to discuss critical aspects of AI development and impact in the precision health space. I am especially excited about the promise of purpose-built AI models for biomedical space that can connect heterogeneous genomic and molecular data with clinical outcomes, enabling precise diagnosis, treatment, and accelerating next-generation drug development." - Dr. Olga Troyanskaya, Director at Princeton Precision Health, Professor at Princeton University and Deputy Director for Genomics at the Flatiron Institute of the Simons Foundation

"What a delight to be part of the amazing group of startups, investors and scientists at the 2024 LDV Vision Summit. In a deep (and meta) way, it shone a light on some of the most interesting startups and science that showcase the potential of visual technologies and AI to improve life for people around the world for years to come. Very inspiring!” - Esther Dyson, an investor, author, commentator, philanthropist and full-time founder of Wellville

“The 2024 LDV summit was a phenomenal opportunity to learn about business trends in vision technology. I am now even more convinced and impressed by the pivotal role of vision science in innovation. The program was a perfect mixture of tech and entrepreneurship. Thanks, Evan for including me in this amazing panel of scientists, founders and investors. It was a privilege to present to such an amazing audience.” - Dr. Sid Kouider, Director of Engineering & Research at Snap

“It was an absolute pleasure to moderate a discussion with three investors on the next billion-dollar opportunities. Their expertise and insights not only made for a lively and educational conversation for the audience but also taught me so much about cutting edge technologies and how they're navigating them as venture capitalists.” - Kia Kokalitcheva, Senior Reporter at Axios

"Attending the LDV Tech Summit was an enlightening experience, as always, immersed in a series of talks, panels, and fireside chats spanning across scientists, investors, and entrepreneurs. It was a unique convergence of deep visual and AI technologies shaping the future of life sciences, and I eagerly anticipate returning next year to witness the continued advances in these dynamic spaces” - Dr. David Rabuka, co-founder, CEO and President at Acrigen Biosciences and our LDV Capital Expert

“This was my first Annual LDV Vision Summit and I hope I'm invited back! It was an incredible opportunity to hear from leaders in the field from a variety of backgrounds. Spatial biology is hugely important and I'm excited to see what the future holds." - Dr. Elizabeth Neumann, an Assistant Professor at the University of California, Davis